The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

About BCISim, Inc

BCISim has discovered a major advancement in diagnosis and treatment with a new technology called predictive neuro-stimulation (PNS) to detect then prevent the occurrence of seizures. Our methodology has been implemented in patients with an 86% accuracy rate in predicting Epileptic seizures before they occur in children 8-12 years old. Our methods include finding the small, local area in the individual’s brain where initial seizure activity is measured. As this area grows and begins to take over the individual’s brain, we short-circuit this activity by sending a small electrical stimulation to the individual’s brain, thereby stopping the train of seizure pathologies. We have developed a neuro-device to predict and reduce seizures, and we are looking for investment to increase patient testing to quickly bring our product to market.

BCISim, Inc Headquarter Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

    Discover the right solution for your team

    The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

    Request a demo

    CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.